Date Oct 22 – 25
Venue: The Westin Alexandria, Washington, D.C.
CHI’s Immunogenicity & Bioassay Summit will examine the challenges currently facing the industry and will provide NEW case studies, NEW perspectives and NEW approaches. Hear from the industry, academia and the regulatory authorities. This year 3 Conference Programs will be presented, a Symposium, Training Seminar and many short courses for in-depth study, as well as interactive breakout discussions for sharing of experiences and ideas, and excellent networking opportunities.
It will be a busy week for Perceval Sondag, PharmaLex Senior Manager,Statistics
On Oct 22 and 23 he will be instructing a training seminar titled “Introduction to Design Experiments”. This class is an introduction course to the concept of Design of Experiments. On Oct 24, he will also be presenting on “Assay Performance Qualification: A Fit for Purpose Approach” This talk proposes a fit for purpose method for assay validation in a lifecycle paradigm, while maintaining a reasonable compromise between producer and patient risks. Also on Oct 24 moderating a panel discussion; “Statistical Approaches to Lifecycle Validation”
To learn more about this conference or to register visit http://www.immunogenicitysummit.com/